Rare diseases
Investigational molecules
Locations
Dozsa Gyorgy Utca 15, 3200 Gyongyos, Hungary
Clinexpert Kft. in Gyongyos, Hungary specialises in clinical trials of conditions such as Colitis ulcerative, Crohn's disease, Non-small cell lung cancer, Non-small cell lung cancer metastatic, and other specialisations. This site conducts important research.
At Clinexpert Kft., investigators are exploring innovative approaches to manage atherosclerotic cardiovascular disease and its complications, emphasizing long‑term safety and patient‑centered outcomes.
These studies aim to lower event rates and improve quality of life for individuals at risk of heart disease.
Research at the site focuses on improving treatment for inflammatory bowel disease and primary biliary cholangitis, seeking therapies that alleviate fatigue and cognitive symptoms while ensuring tolerability.
The goal is to provide better symptom control and disease management for patients with chronic digestive disorders.
The oncology program evaluates cutting‑edge treatments for cancers such as non‑small cell lung cancer, tumors with KRAS G12C mutation, and high‑risk early‑stage breast cancer, aiming to enhance survival and personalize care.
These trials strive to extend patient survival and expand therapeutic options across multiple tumor types.
Studies address neuropsychiatric challenges by testing novel compounds for agitation in Alzheimer’s disease, with a focus on safety, tolerability, and improvement of daily functioning.
The aim is to enhance quality of life for individuals living with neurodegenerative conditions and their families.
The site investigates fundamental digestive system physiological processes and their link to oral health, seeking biomarkers and diagnostic tools for early disease detection.
Findings may lead to earlier interventions and targeted therapies for both oral and gastrointestinal health.
Clinical trials currently enrolling participants at this site.
Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
HungaryStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
HungaryStudy on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis
HungaryA Phase 3b Study of Guselkumab Compared with Risankizumab in Adults with Moderately to Severely Active Crohn’s Disease
HungaryA study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis
HungaryStudy Comparing OSE2101 and Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Immunotherapy Resistance
HungaryStudy on Long-Term Safety of BI 907828 for Patients with Solid Tumors Who Previously Participated in a Study with This Medicine
HungaryEvaluation of Trazodone Hydrochloride for Improving Emotional Blunting in Patients with Major Depressive Disorder
HungaryStudy on Datopotamab Deruxtecan and Rilvegostomig for Stage I Non-Small Cell Lung Cancer Patients with ctDNA-Positive or High-Risk Features
HungaryStudy of SYM024, SYM023, and SYM025 in Adults with Advanced Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Expression
HungaryA study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn's disease or ulcerative colitis
HungaryStudy of SAR441566 compared to placebo for adults with moderate to severe Crohn's disease
HungaryMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
